Pregled bibliografske jedinice broj: 736233
Myocardial Clearance of Tc-99m Hexakis-2-Methoxy-2-Methylpropyl Isonitrile (MIBI) in Patients with Coronary Artery Disease
Myocardial Clearance of Tc-99m Hexakis-2-Methoxy-2-Methylpropyl Isonitrile (MIBI) in Patients with Coronary Artery Disease // Clinical Nuclear Medicine, 15 (1990), 5; 307-312 doi:10.1097/00003072-199005000-00005 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 736233 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Myocardial Clearance of Tc-99m Hexakis-2-Methoxy-2-Methylpropyl Isonitrile (MIBI) in Patients with Coronary Artery Disease
Autori
Franceschi, Maja ; Guimond, Jean ; Zimmerman, Robert E. ; Picard, Michel V. ; English, Robert J. ; Carvalho, Paulo A. ; Tumeh, Sabah S. ; Holman, Leonard B.
Izvornik
Clinical Nuclear Medicine (0363-9762) 15
(1990), 5;
307-312
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Myocardial clearance ; MIBI ; Coronary artery disease
Sažetak
Myocardial clearance of the new cationic, lypophilic myocardial perfusion agent, Tc-99m-hexakis-2-methoxy-2-methylpropyl isonitrile (MIBI) was studied in 9 patients with coronary artery disease. Regional time-activity curves were determined from serial post exercise myocardial SPECT images after a single dose of Tc-99m MIBI. It is concluded that, while redistribution is substantially slower than with TI-201, image interpretation and data evaluation should be approached cautiously when imaging is delayed 4 hours or more after injection of >Tc-99m MIBI. Quantitative techniques aimed at evaluating the extent and intensity of myocardial ischemia will be particularly affected.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
